STUTTGART, GERMANY (UroToday.com) - The current role of immunotherapy of metastatic kidney cancer in the era of targeted therapy was investigated with a survey among German urologists and oncologists - in private practice and in hospital.
Your session will expire in 8 hours requiring you to log in each day to view content.


